HIF1A and prostate cancer: Indeed, upregulation of HIF-1α expression is observed in multiple cancers, including colon cancer, breast cancer, prostate cancer, chronic myelogenous leukemia, glioblastoma, rhabdomyosarcoma, and leukemia [33–35].